These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34036258)

  • 1. Surveillance for Outcomes Selected as Atrial Fibrillation Quality Indicators in Canada: 10-Year Trends in Stroke, Major Bleeding, and Heart Failure.
    Wilton SB; Kaul P; Islam S; Atzema CL; Cruz J; MacFarlane K; McKelvie R; Poon S; Lambert L; Rush K; Deyell M; Wyse DG; Cox JL; Skanes A; Sandhu RK
    CJC Open; 2021 May; 3(5):609-618. PubMed ID: 34036258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHA
    Peacock WF; Tamayo S; Patel M; Sicignano N; Hopf KP; Yuan Z
    Ann Emerg Med; 2017 May; 69(5):541-550.e1. PubMed ID: 27913059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial.
    Ha ACT; Verma S; Mazer CD; Quan A; Yanagawa B; Latter DA; Yau TM; Jacques F; Brown CD; Singal RK; Yamashita MH; Saha T; Teoh KH; Lam BK; Deyell MW; Wilson M; Hibino M; Cheung CC; Kosmopoulos A; Garg V; Brodutch S; Teoh H; Zuo F; Thorpe KE; Jüni P; Bhatt DL; Verma A;
    JAMA Netw Open; 2021 Aug; 4(8):e2121867. PubMed ID: 34448866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA2DS2-VASc Score.
    Lin YS; Chen YL; Chen TH; Lin MS; Liu CH; Yang TY; Chung CM; Chen MC
    JAMA Netw Open; 2018 Aug; 1(4):e180941. PubMed ID: 30646091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Trends in Population Rates of Incident Atrial Fibrillation and Atrial Flutter Hospitalizations, Stroke Risk, and Mortality Show Decline in Hospitalizations.
    Sandhu RK; Wilton SB; Islam S; Atzema CL; Deyell M; Wyse DG; Cox JL; Skanes A; Kaul P
    Can J Cardiol; 2021 Feb; 37(2):310-318. PubMed ID: 32360794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
    Savarese G; Giugliano RP; Rosano GM; McMurray J; Magnani G; Filippatos G; Dellegrottaglie S; Lund LH; Trimarco B; Perrone-Filardi P
    JACC Heart Fail; 2016 Nov; 4(11):870-880. PubMed ID: 27614940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting stroke and death in patients with heart failure using CHA
    Son MK; Lim NK; Park HY
    BMC Cardiovasc Disord; 2019 Aug; 19(1):193. PubMed ID: 31395009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
    Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).
    Lip GYH; Merino JL; Dan GA; Themistoclakis S; Ellenbogen KA; De Caterina R; Goudev A; Jin J; Melino M; Winters SM; Goette A
    Am J Cardiol; 2018 Jan; 121(2):193-198. PubMed ID: 29169605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality Prediction of the CHA
    Morrone D; Kroep S; Ricci F; Renda G; Patti G; Kirchhof P; Chuang LH; van Hout B; De Caterina R
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.
    Lip GY; Skjøth F; Rasmussen LH; Larsen TB
    J Am Coll Cardiol; 2015 Apr; 65(14):1385-94. PubMed ID: 25770314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke and Systemic Thromboembolism according to CHA
    Lee KB; Kim TH; Park J; Park JK; Kang KW; Kim J; Park HW; Choi EK; Kim JB; Lee YS; Shim J; Joung B
    Yonsei Med J; 2022 Apr; 63(4):317-324. PubMed ID: 35352882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA
    Lee JM; Kim JB; Uhm JS; Pak HN; Lee MH; Joung B
    Heart Rhythm; 2017 Sep; 14(9):1297-1301. PubMed ID: 28559088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.